Nurse Practitioner, Psychiatric/Mental Health · Lyons, NY
NPI
1396777132
Since 2006
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
7
Medicare group memberships
Hospitals
3
Hospital affiliations
1519 Nye Rd, Wayne Behavioral Network Suite 1000
Lyons, NY, 14489
Phone (315) 946-5722
Groups this clinician bills Medicare through
Medicare paid, 2022
$2,636
53 services
Medicare patients, 2022
12
Average age 46
Drug cost, 2024
$1.7M
13,217 prescriptions
Company payments, 2025
$822
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Janine Quinlan prescribed most often to Medicare patients was Olanzapine, with 959 prescriptions and refills. In total Janine Quinlan wrote 13,217 Medicare prescriptions that cost $1.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-18.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Olanzapine Generic | 959 | 969 | 94 | $16K |
| Risperidone Generic | 763 | 775 | 77 | $13K |
| Lorazepam Generic | 725 | 725 | 156 | $12K |
| Clozapine Generic | 691 | 691 | 52 | $56K |
| Quetiapine Fumarate Generic | 678 | 703 | 69 | $16K |
| Propranolol Hcl Generic | 610 | 630 | 63 | $15K |
| Clonazepam Generic | 572 | 574 | 91 | $7,092 |
| Aripiprazole Generic | 461 | 487 | 63 | $22K |
| Sertraline Hcl Generic | 405 | 423 | 53 | $4,270 |
| Fluoxetine Hcl Generic | 395 | 405 | 36 | $4,487 |
| Divalproex Sodium Generic | 381 | 381 | 45 | $17K |
| Mirtazapine Generic | 381 | 382 | 46 | $7,087 |
| Benztropine Mesylate Generic | 364 | 372 | 56 | $4,253 |
| Trazodone Hcl Generic | 322 | 322 | 39 | $3,375 |
| Divalproex Sodium Er Divalproex Sodium | 321 | 321 | 32 | $19K |
Brand drugs: 467 claims; generic drugs: 12,750 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Janine Quinlan $822 ($822 in general payments such as food, travel and fees) from 10 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $353.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 10 | $353 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $159 |
| Alkermes, Inc. ALKS | 8 | $136 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $42.76 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $30.42 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $22.68 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $22.33 |
| Lundbeck LLC | 1 | $22.09 |
| Abbvie Inc. ABBV | 1 | $17.53 |
| Axsome Therapeutics, Inc. AXSM | 1 | $16.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.